Synthesis and immunological evaluation of M protein targeted tetra-valent and tri-valent group A streptococcal vaccine candidates based on the lipid-core peptide system

International Journal of Peptide Research and Therapeutics

Volumn 12, Issue 3, 2006, Pages 317-326

  Moyle, Peter Michael ^a   Olive, Colleen ^b   Karpati, Levente ^a   Barozzi, Nadia ^a   Ho, Mei Fong ^b   Dyer, Joanne ^b   Sun, Hsien Kuo ^b   Good, Michael ^b   Toth, Istvan ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

Author keywords

Adjuvants; Group A streptococcus; Lipid core peptide system; Lipoamino acids; M protein; Multiple antigen peptide system; Solid phase peptide synthesis; Vaccination

Indexed keywords

FREUND ADJUVANT; IMMUNOGLOBULIN G ANTIBODY; LIPID; M PROTEIN; PEPTIDE; STREPTOCOCCUS VACCINE;

AMINO TERMINAL SEQUENCE; ANIMAL EXPERIMENT; ANTIBODY BLOOD LEVEL; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; DRUG SCREENING; DRUG SYNTHESIS; FEMALE; MOUSE; NONHUMAN; PEPTIDE SYNTHESIS;

STREPTOCOCCUS SP. 'GROUP A'; TETRA;

EID: 33745851844     PISSN: 15733149     EISSN: 15733904     Source Type: Journal    
DOI: 10.1007/s10989-006-9021-8     Document Type: Article

References (44)

1. Batzloff, M. R., Sriprakash, K. S. and Good, M. F.: 2004, Curr. Drug. Targets. 5, 57-69.
2. Beachey, E. H., Bronze, M. S., Dale, J. B., et al.: 1988, Vaccine. 6, 192-196.
3. Brandt, E. R., Sriprakash, K. S., Hobb, R. I., et al.: 2000a, Nat. Med. 6, 455-459.
4. Brandt, E. R., Teh, T., Relf, W. A., Hobb, R. I. and Good, M. F.: 2000b, Infect. Immun. 68, 6587-6594.
5. Carapetis, J. R. and Currie, B. J.: 1998, Med. J .Aust. 168, 428-429.
6. Carapetis, J. R., Steer, A. C., Mulholland, E. K. and Weber, M.: 2005, Lancet Infect. Dis. 5, 685-694.
7. Carapetis, J. R., Wolff, D. R. and Currie, B. J.: 1996, Med. J. Aust. 164, 146-149.
8. Dakappagari, N. K., Pyles, J., Parihar, R., et al.: 2003, J. Immunol. 170, 4242-4253.
9. Dale, J. B.: 1999, Vaccine. 17, 193-200.
10. Dale, J. B., Chiang, E. Y. and Lederer, J. W.: 1993. J. Immunol. 151, 2188-2194.
11. Dale, J. B. and Lederer, J. W.: 2000, In U.S.(University of Tennessee Research Corporation, USA). Us, pp. 62 pp., Cont.-in-part of U.S. Ser. No. 945,954, abandoned.
12. Dale, J. B., Simmons, M., Chiang, E. C. and Chiang, E. Y.: 1996, Vaccine. 14, 944-948.
13. Fischetti, V. A.: 1989, Clin. Microb. Rev. 2, 285-314.
14. France, L. L., Piatti, P. G., Newman, J. F. E., et al.: 1994, Proc. Natl. Acad. Sci. USA. 91, 8442-8446.
15. Gahéry-Ségard, H., Pialoux, G., Charmeteau, B., et al.: 2000, J. Virol. 74, 1694-1703.
16. Gibbons, W. A., Hughes, R. A., and Charalambous M., et al.: (1990) Liebigs Ann Chem. 1175-1183.
17. Gras-Masse, H.: 2001, Mol. Immunol. 38, 423-431.
18. Hayman, W. A., Brandt, E. R., Relf, W. A., et al.: 1997, Int. Immunol. 9, 1723-1733.
19. Horvath, A., Olive, C., Karpati, L., et al.: 2004, J. Med. Chem. 47, 4100-4104.
20. Horváth, A., Olive, C., Karpati, L., et al.: 2004, J. Med. Chem. 47, 4100-4104.
21. Horváth, A., Olive, C., Wong, A., et al.: 2002a, J. Med. Chem. 45, 1387-1390.
22. Horváth, A., Olive, C., Wong, A., et al.: 2002b, Lett. Pept. Sci. 8, 285-288.
23. Hruby, D. E., Hodges, W. M., Wilson, E. M., Franke, C. A. and Fischetti, V. A.: 1988, Proc. Natl. Acad. Sci. USA. 85, 5714-5717.
24. Hu, M. C., Walls, M. A., Stroop, S. D., et al.: 2002, Infect. Immun. 70, 2171-2177.
25. Ji, Y. D., Carlson, B., Kondagunta, A. and Cleary, P. P.: 1997, Infect. Immun. 65, 2080-2087.
26. Jung, G., Wiesmüller, K. H., Becker, G., Bühring, H.-J. and Bessler, W. G.: 1985, Angew Chem. Int. Ed. Engl. 24, 872-873.
27. Kent, S. B.: 1988, Annu. Rev. Biochem. 57, 957-989.
28. Kotloff, K. L., Corretti, M., Palmer, K., et al.: 2004, JAMA. 292, 709-715.
29. Lancefield, R. C.: 1959, J. Exp. Med. 110, 271-292.
30. Lancefield, R. C.: 1962, J. Immunol. 89, 307-313.
31. Livingston, B. D., Newman, M., Crimi, C., et al.: 2001, Vaccine. 19, 4652-4660.
32. Lussow, A. R., Aguado, M. T., Del Giudice, G. and Lambert, P.-H.: 1990, Immunol. Lett. 25, 255-264.
33. Martin, D. and Sriprakash, K. S.: 1997, in V. Asche (eds.) Recent Advances in Microbiology. Australian Society for Microbiology, Melbourne, pp. 1-40.
34. McNeil, S. A., Halperin, S. A., Langley, J. M., et al.: 2005, Clin. Infect. Dis. 41, 1114-1122.
35. Metzger, J. W., Beck-Sickinger, A. G., Loleit, M., et al.: 1995, J Peptide Sci. 1, 184-190.
36. Muhlradt, P. F., Kiess, M., Meyer, H., Sussmuth, R. and Jung, G.: 1997, J. Exp. Med. 185, 1951-1958.
37. Olive, C., Batzloff, M., Horváth, A., et al.: 2004, Indian J. Med. Res. 119, 88-94.
38. Olive, C., Batzloff, M., Horváth, A., et al.: 2003, Infect. Immun. 71, 2373-2383.
39. Olive, C., Batzloff, M. R., Horváth, A., et al.: 2002, Infect. Immun. 70, 2734-2738.
40. Pruksakorn, S., Currie, B., Brandt, E., et al.: 1994, Int. Immunol. 6, 1235-1244.
41. Sarin, V. K., Kent, S. B. H., Tam, J. P. and Merrifield, R. B.: 1981, Anal. Biochem. 117, 147-157.
42. Schnölzer, M., Alewood, P., Jones, A., Alewood, D. and Kent, S. B.: 1992, Int. J. Pept. Protein Res. 40, 180-193.
43. Tam, J. P.: 1988, Proc. Natl. Acad. Sci. USA. 85, 5409-5413.
44. Toth, I., Danton, M., Flinn, N. and Gibbons, W. A.: 1993, Tetrahedron Lett. 34, 3925-3928.